🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will test two different formulations. The results will be used t...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2009-04
Trial ID
NCT00861458
Treatments Being Tested
The purpose of this study is to estimate the effect of filibuvir on the pha...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2010-06
Trial ID
NCT00918476
Treatments Being Tested
Phase 1 study in HVC (Hepatitis C Virus) infected subjects to determine pha...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2008-04
Trial ID
NCT00671671
Treatments Being Tested
Filibuvir, a CYP3A4 inhibitor is being developed for the treatment of chron...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2011-02
Trial ID
NCT01210404
Treatments Being Tested
Assess the safety, tolerability and pharmacokinetics of multiple oral doses...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2007-01
Trial ID
NCT00445315
Treatments Being Tested
The purpose of this study is to further assess the potency of PF-00868554, ...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2008-08
Trial ID
NCT00720434
Treatments Being Tested
This is a phase 1 study to assess the routes of elimination of a single ora...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2009-01
Trial ID
NCT00823745
Treatments Being Tested
The metabolism of PF-00868554 is primarily mediated by CYP3A, and it is ant...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2008-02
Trial ID
NCT00651027
A single dose of PF-00868554 (filibuvir) will be safety and tolerable in Ja...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2010-02
Trial ID
NCT01051232